Infantile hemangioma is the most common vascular tumor in newborns, with an incidence from 12 to 23% among preterm infants with low weight at birth and a female to male ratio of 3:1. The head and neck is the most frequently affected area (60%), and the scalp is a typical site for such large lesions.
Objective:
We describe some clinical and medical aspects in comparison with the surgical approach to giant infantile hemangioma of the scalp.
Methods:
The indications to treatment are discussed. An outcome basis evaluation, by reviewing some clinical cases, is provided to help readers better understand when and how to undergo surgery safely.
Conclusion:
Early excision of huge infantile hemangioma of the scalp is the treatment of choice if feasible within 5 months of age.
Get full access to this article
View all access options for this article.
References
1.
EnjolrasOWassefMChapotR. Color atlas of vascular tumors and vascular malformations. Paris: Cambridge University Press; 2007.
2.
SmolinskiKYanAC. Hemangiomas of infancy: Clinical and biological characteristics. Clin Pediatr2005;44:747–66, doi:10.1177/000992280504400902.
3.
HaggstromANLammerEJSchneiderRA. Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics2006;117:698–703, doi:10.1542/peds.2005-1092.
4.
WanerMNorthPSchererKA. The non-random distribution of facial hemangiomas. Arch Dermatol2003;139: 869–75, doi:10.1001/archderm.139.7.869.
5.
HandJLFriedenIJ. Vascular birthmarks of infancy: Resolving nosologic confusion. Am J Med Genet2002;108:257–64, doi:10.1002/ajmg.10161.
6.
WassefMEnjolrasO. Les malformations vasculaires superficielles: Classification et histopathologie. Ann Pathol1999;19:253–64.
ChillerKGPassaroDFriedenIJ. Hemangiomas of infancy: Clinical characteristic, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol2002;138:1567–76, doi:10.1001/archderm.138.12.1567.
9.
GarzonMCEnjolrasOFriedenIJ. Vascular tumors and vascular malformations: Evidence for an association. J Am Acad Dermatol2000;42:275–9.
10.
DethlefsenSMMullikenJBGlowackiJ. An ultrastructural study of mast cells interactions in hemangiomas. Ultrastruct Pathol1986; 10:175, doi:10.3109/01913128609014593.
11.
MullikenJB. Vascular malformations of the head and neck. In: MullikenJBYoungAE, editors. Vascular birthmarks: hemangiomas and malformations. Philadelphia: WB Saunders; 1988. p. 301–42.
12.
FinnMCGlowackiJMullikenJB. Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg1983;18: 894, doi:10.1016/S0022-3468(83)80043-8.
13.
EnjolrasOMullikenJB. Vascular tumors and vascular malformations (new issues). Adv Dermatol1997;13:375–423.
14.
MarlerJJFishmanSJKilroySM. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics2005;116:38–45, doi:10.1542/peds.2004-1518.
15.
ChillerKGFriedenIJArbiserJL. Molecular pathogenesis of vascular anomalies. Classification into three categories based upon clinical and biochemical characteristics. Lymphat Res Biol2003;1: 267–82, doi:10.1089/153968503322758076.
16.
CohenMM. Vasculogenesis, angiogenesis, hemangiomas and vascular malformations. Am J Med Genet2002;108:265–74, doi:10.1002/ajmg.10260.
17.
BeckDOGosainAK. The presentation and management of hemangiomas. Plast Reconstr Surg2008;123:181–91, doi:10.1097/PRS.0b013e3181a65c59.
18.
RosslerJWehlGNiemeyerCM. Evaluating systemic prednisone therapy for proliferating hemangioma in infancy. Eur J Pediatr2008;167:813–5, doi:10.1007/s00431-007-0561-5.
19.
BennettMLFleischerABChamlinSL. Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol2001;137:1208–13.
20.
BartosheskyLEBullMFeingoldM. Corticosteroid treatment of cutaneous hemangiomas: How effective? A report on 24 children. Clin Pediatr1978;17:2625–38, doi:10.1177/000992287801700807.
21.
CohenSRWangCI. Steroid treatment of hemangioma of the head and neck in children. Ann Otol Rhinol Laryngol1972;81:584–90.
22.
TabanMGoldbergRA. Propranolol for orbital hemangioma. Ophthalmology2010;117:195–5:e4, doi:10.1016/j.ophtha.2009.08.040.
23.
MarscianiAPericoliRAlaggioR. Massive response of severe infantile hepatic hemangioma to propranolol. Pediatr Blood Cancer2010;54:176, doi:10.1002/pbc.22262.
RösslerJSchillTBährA. Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy—a retrospective, single centre study. J Eur Acad Dermatol Venereol2011 Oct 31. DOI: 10.1111/j.1468-3083.2011.04314.x.
26.
MichelJPaturalH. Response to oral propranolol therapy for ulcerated hemangiomas in infancy. Arch Pediatr2009;16:1565–8, doi:10.1016/j.arcped.2009.09.008.
27.
Léautè-LabrèzeCDumas de la RoqueEHubicheT. Propranolol for severe hemangiomas of infancy. N Engl J Med2008;358:2649–51, doi:10.1056/NEJMc0708819.
28.
SiegfriedECKeenanWJAl-JureidiniS. More on propranolol for hemangiomas of infancy. N Engl J Med2008;359:2846–7, doi:10.1056/NEJMc086443.
29.
HoyouxC. Vincristine treatment for management of alarming hemangiomas in infancy. Rev Med Liege2008;63:14–7.
30.
Brandling-BennettHAMetryDW. Infantile hemangiomas with unusually prolonged growth fase: A case series. Arch Dermatol2008;144:1632–7, doi:10.1001/archderm.144.12.1632.
31.
GlotzbachJPLeviBWongVW. The basic science of vascular biology: Implications for the practicing surgeon. Plast Reconstr Surg2010;126:1528, doi:10.1097/PRS.0b013e3181ef8ccf.
32.
BarlowCFPriebeCJMullikenJB. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr1998;132:527–30, doi:10.1016/S0022-3476(98) 70034-4.
33.
FawcettSLGrantIHallPN. Vincristine as a treatment for a large hemangioma threathening vital functions. Br J Plast Surg2004;57:168–71, doi:10.1016/j.bjps.2003.11.003.
34.
ChakkittakandiyilAPhillipsRFriedenIJ. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: A retrospective, multicenter, cohort study. Pediatr Dermatol2012;29: 28–31, doi:10.1111/j.1525-1470.2011.01664.x.
35.
KhungerNPahwaM. Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome. Br J Dermatol2011;164:886–8, doi:10.1111/j.1365-2133.2010.10177.x.
36.
PopeEChakkittakandiyilA. Topical timolol gel for infantile hemangiomas: A pilot study. Arch Dermatol2010;146:564–5, doi:10.1001/archdermatol.2010.67.
37.
HarrisPAOliverNKSlaterP. Safety of neonatal cleft lip repair. J Plast Surg Hand Surg2010;44:231–6, doi:10.3109/02844311.2010.499666.
38.
ZhengJWWangYAZhouGY. Head and neck hemangiomas: How and when to treat. Shangai Kou Qiang Yi Xue2007;16:337–42.
39.
AdouaniABouguilaJAbdelaliMA. Place du traitement chirurgical précoce dans les hémangiomes périorificiels de la face. Ann Chir Plast Esthet2008;53:435–40.
40.
SpectorJABleiFZideBM. Early surgical intervention for proliferating hemangiomas of the scalp: Indications and outcomes. Plast Reconstr Surg2007;1097:457–62.
41.
EnjolrasORicheMCMerlandJJEscandeJP. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics1990;85:491–8.
42.
DuboisJGarelL. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol1999;29:879–93, doi:10.1007/s002470050718.
43.
GriseyARothPMartinA. Diagnostic prénatal et prise en charge d'un cas d'heémangiome congénital du cuir chevelu. J Gynecol Obstet Biol Reprod2006;35:405–10, doi:10.1016/S0368-2315(06)76412-2.
44.
PicardAFranchiGDelbequeM. La chirurgie du cuir chevelu de l'enfant: Principes et particularitiés thérapeutiques. Rev Stom Chir Maxillo-Faciale2005;6:334–43, doi:10.1016/S0035-1768(05)86056-5.
45.
MuellerCKBaderRDEwaldC. Scalp defect repair: A comparative analysis of different surgical techniques. Ann Plast Surg2011 Jun 8. DOI:10.1097/SAP.0b013e318218f32a.
KazanjianVH. Repair of partial losses of the scalp. Plast Reconstr Surg1953;12:325–34, doi:10.1097/00006534-195311000-00003.
48.
BarryRBLawrenceCMLangtryJA. The use of galeotomies to aid the closure of surgical defects on the forehead and scalp. Br J Dermatol2009;160:875–7, doi:10.1111/j.1365-2133.2009.09053.x.
49.
HudsonDALazarusDSilfenR. The use of serial tissue expansion in pediatric plastic surgery. Ann Plast Surg2000;45:589–93, doi:10.1097/00000637-200045060-00003.
50.
DonelanMBGarciaJA. Purse-string closure of scalp defects following tissue expansion: An effective aesthetic alternative. J Plast Reconstr Aesthet Surg2008;61:419–22, doi:10.1016/j.bjps.2007.02.002.
51.
WuJKRohdeCH. Purse-string closure of hemangiomas: Early results of a follow-up study. Ann Plast Surg2009;62:581–5, doi:10.1097/SAP.0b013e31819fb1e2.
